Menu
Back to Journals » Clinical Ophthalmology » Volume 12
Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]
Authors Nichols KK , Holland E, Toyos MM , Peace JH, Majmudar P, Raychaudhuri A, Hamdani M, Roy M, Shojaei A
Received 22 March 2018
Accepted for publication 22 March 2018
Published 17 May 2018 Volume 2018:12 Pages 913—914
Nichols KK, Holland E, Toyos MM, et al. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial. Clin Ophthalmol. 2018;12:263–270.
On page 266, both mentions of Figure 3, should be Figure 4.
On page 267, Figure 4 is drawn incorrectly.
Read the original article.
© 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.